Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT02976766
PHASE2

Adjunctive Gypenosides for Acute Optic Neuritis

Sponsor: First Affiliated Hospital of Guangxi Medical University

View on ClinicalTrials.gov

Summary

This pilot randomized, double-blind, placebo-controlled trial evaluated whether short-course adjunctive gypenosides, added to standard corticosteroid treatment, may preserve retinal structural outcomes in adults with acute optic neuritis.

Official title: Adjunctive Gypenosides for Acute Optic Neuritis: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2017-02-04

Completion Date

2018-07-30

Last Updated

2026-05-20

Healthy Volunteers

No

Conditions

Interventions

DRUG

Gypenosides

Participants received gypenosides 180 mg/day, given as 60 mg three times daily for 10 days, started on the first day of intravenous methylprednisolone. All participants also received standard corticosteroid treatment.

DRUG

Placebo

Participants received matching placebo capsules three times daily for 10 days, started on the first day of intravenous methylprednisolone. All participants also received standard corticosteroid treatment.

Locations (1)

The First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China